Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer

Gynecologic Oncology
Jason D WrightJanet S Rader

Abstract

To report the utility of the monoclonal, anti-vascular endothelial growth factor antibody bevacizumab in combination with cytotoxic chemotherapy for women with recurrent cervical cancer. A retrospective analysis of women with recurrent cervical cancer treated with bevacizumab combination therapy was performed. Six patients were identified. The patients had a median of 3 prior regimens. All of the patients had multisite, metastatic disease. The combination regimen included IV 5-fluorouracil in 5 (83%) patients and capecitabine in one (17%) subject. Treatment was well tolerated. Grade 4 toxicity occurred in one patient who developed neutropenic sepsis. Clinical benefit (CR, PR, or SD) was noted in 67% of the subjects. This included 1 (17%) complete response, 1 (17%) partial response and two (33%) patients with stable disease. The median time to progression for the four women who demonstrated clinical benefit was 4.3 months. Combination bevacizumab is well tolerated and displayed encouraging anti-tumor activity in heavily pretreated recurrent cervical cancer.

References

Nov 1, 1989·Gynecologic Oncology·G M SommersM A Lockett
Oct 8, 1998·Cancer·T KakuH Nakano
Apr 15, 1999·The New England Journal of Medicine·P G RoseS Insalaco
Sep 16, 1999·American Journal of Obstetrics and Gynecology·C J WangJ D Lin
Oct 25, 2002·International Journal of Cancer. Journal International Du Cancer·Barbara BachtiaryRichard Pötter
Aug 2, 2003·The New England Journal of Medicine·James C YangSteven A Rosenberg
Oct 11, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Holly H GallionUNKNOWN Gynecologic Oncology Group Study
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patricia J EifelDavid G Mutch
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
Jul 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David H MooreThomas F Rocereto
Sep 1, 2004·International Journal of Radiation Oncology, Biology, Physics·Ji-Hong HongSwei Hsueh
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
May 4, 2005·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Hamza M MuslumanogluS Artan
May 11, 2005·Gynecologic Oncology·Alfred D JenkinsCharles Levenback
May 25, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harry J LongUNKNOWN Gynecologic Oncology Group Study
Aug 23, 2007·Nature Clinical Practice. Cardiovascular Medicine·Rakesh K JainRenu Virmani
Apr 26, 2008·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·S W JungH S Ryu

❮ Previous
Next ❯

Citations

Oct 18, 2014·Investigational New Drugs·Gerald S FalchookRazelle Kurzrock
Dec 18, 2008·Future Oncology·Dirk O BauerschlagJakobus Pfisterer
Nov 8, 2011·Archives of Gynecology and Obstetrics·Shuping ZhaoZenyan Wang
Jan 23, 2016·Expert Opinion on Biological Therapy·Nicolò BizzarriSimone Ferrero
Nov 12, 2013·Expert Opinion on Pharmacotherapy·Alfonso Dueñas-GonzalezRigoberto Dolores
Jan 17, 2014·Expert Review of Anticancer Therapy·Laurie M Elit, Hal Hirte
Apr 26, 2012·Expert Opinion on Emerging Drugs·Alfonso Dueñas-GonzalezDiana Cervantes-Madrid
Jun 26, 2012·Cancer Treatment Reviews·Giannis MountziosChristos A Papadimitriou
Apr 17, 2012·Gynecologic Oncology·Flora ZagouriRupert Bartsch
Jan 17, 2012·Surgical Oncology·M PeirettiA Maggioni
Nov 8, 2011·Critical Reviews in Oncology/hematology·Filippo BellatiMarianna Nuti
Jul 28, 2015·American Journal of Obstetrics and Gynecology·Krista S Pfaendler, Krishnansu S Tewari
Jun 12, 2008·Gynecologic Oncology·Josep Maria del CampoMarta Parera
Jun 6, 2008·Gynecologic Oncology·Xia TaoJohn J Kavanagh
May 20, 2009·Cancer·Sujana MovvaClaire Verschraegen
Mar 2, 2016·Clinical Therapeutics·Sarah M Crafton, Ritu Salani
Jan 17, 2015·Clinical Therapeutics·Lauren S Krill, Krishnansu S Tewari
Apr 26, 2015·Virologica Sinica·Liyan Jin, Zhi-Xiang Xu
Dec 3, 2014·Archives of Medical Research·Joaquín Manzo-MerinoMarcela Lizano
Oct 18, 2016·Expert Review of Anticancer Therapy·Lindsey E Minion, Krishnansu S Tewari
Feb 22, 2017·Experimental Cell Research·Beverly R WuertzFrank G Ondrey
Dec 10, 2017·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A Godoy-OrtizA Sánchez-Muñoz
Nov 5, 2014·Therapeutic Advances in Medical Oncology·Ramez N Eskander, Krishnansu S Tewari
Nov 18, 2018·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·H-Y LinC-W Hsu
Feb 22, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Takeshi HisamatsuTadashi Kimura
May 4, 2013·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Floor J BackesDavid M O'Malley
Aug 5, 2010·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Henry Charles KitchenerUNKNOWN Cervical Cancer Consensus Group
Jul 11, 2009·Expert Review of Anticancer Therapy·Lyndsay J Willmott, Bradley J Monk
Mar 31, 2016·The Oncologist·Jill K Alldredge, Krishnansu S Tewari
May 21, 2015·American Society of Clinical Oncology Educational Book·Helen J MackayLinda Mileshkin
Jan 15, 2019·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Giuseppa MalteseDomenica Lorusso
May 10, 2017·Medical Oncology·Daniela LuveroRoberto Angioli
Apr 4, 2018·Current Oncology Reports·Gloria MarquinaAntonio Casado
Jan 1, 2015·Gynecologic Oncology Research and Practice·Victor Rodriguez-Freixinos, Helen J Mackay
Mar 5, 2021·The Cochrane Database of Systematic Reviews·Yunhai ChuaiAiming Wang
May 2, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Dinesh Kumar ChellappanKamal Dua

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Bradley J MonkLynda Roman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Harry J LongGynecologic Oncology Group Study
© 2022 Meta ULC. All rights reserved